MedTrace Logo

Efficacy of Celecoxib vs Placebo to Prevent Pain in a Paced Walk

NCT00194090 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-08-26

No results posted yet for this study

Summary

A paced 20-minute walk is a reproducible model for acute pain in knee osteoarthritis

Conditions

Interventions

DRUG

celecoxib

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • University Hospitals Cleveland Medical Center

    lead OTHER

Principal Investigators

  • Michele M Hooper, MD, MS · University Hospitals Cleveland Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
45 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-06-30
Primary Completion
2005-09-01
Completion
2005-09-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00194090 on ClinicalTrials.gov